Relationship Between Gonadal Hormone Levels and Symptom Severity in Female Patients With Schizophrenia.

Objective: It is thought that sex-specific differences in schizophrenia may be associated with gonadal hormones, especially estrogen. This study aimed to investigate the relationship between follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin, estradiol, and progesterone serum levels and symptom severity during the menstrual cycle in female patients with schizophrenia. Methods: Serum samples were taken in the follicular and periovulatory phases from 32 female patients with schizophrenia; and FSH, LH, prolactin, estradiol, and progesterone levels were performed. Simultaneously, the patients were administered positive and negative symptom scale (PANSS), Calgary depression scale for schizophrenia (CDSS), and Hamilton anxiety rating scale (HAM-A). Results: PANSS (z = -2.52, P < .001), HAM-A (z = -3.60, P < .001), and CDSS (z = -2.52, P = .012) scores were lower in the periovulatory phase than in the follicular phase. Negative correlations between FSH and PANSS positive symptom subscale (r = -0.393, P = .035), and between prolactin and PANSS total score (r = -0.406, P = .029) were detected. Conclusion: Hypoestrogenism should be studied more in patients with schizophrenia. Studies with large samples evaluating FSH, LH, prolactin, and progesterone together with estrogen are needed to be able to safely use gonadal hormones, which may be related to schizophrenia symptom severity, especially in patients who do not respond adequately to treatment.

[The Effect of Chronic Cigarette Use on Cognitive Function]. / Kronik Sigara Kullaniminin Bilissel Islevler Üzerine Etkisi.

OBJECTIVE: In this study, we aimed to investigate the effect of chronic cigarette smoking on the cognitive function in people who have no other mental or physical illness other than tobacco use disorder. METHOD: The study was carried out on three groups: smokers (n = 71), former smokers (n = 39), and non-smokers (n = 49). The Wisconsin Card Sorting Test (WCST), Stroop Color and Word Test (ST), Trail Making Test (TMT), Auditory Verbal Learning Test (AVLT), and Serial Digit Learning Test (SDLT) were applied to the 3 groups participating in the study. Groups were compared with the Three-Factor Covariance Analysis. RESULTS: Stroop test 4th card time score which determined the basic level of color discourse in the smoker group was significantly higher than the non-smoker group. The Trail Making Test-B time scores were significantly higher in the smoker group than the non-smoker group. And Trail Making Test-B time points were significantly higher in the former smoker group than nonsmoker group. Auditory Verbal Learning Test - verbal learning scores were lower in the smoker group than the non-smoker and former smoker group. There was no significant difference in verbal learning scores between the non-smoking and former smoker groups. The neurocognitive deficits in smokers appear to be related to dose and duration. CONCLUSION: This study suggests that auditory verbal memory, visualspatial processing, and attention areas may be a selective area of disability in smokers. A major limitation is the fact that general cognitive performance levels of participants was not assessed by a general criteria such as Wechsler Adult Intelligence Scale (WAIS).